Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Prepaid Assets: 2010-2024

Historic Prepaid Assets for Ligand Pharmaceuticals (LGND) over the last 15 years, with Dec 2024 value amounting to $8.8 million.

  • Ligand Pharmaceuticals' Prepaid Assets fell 64.61% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 64.61%. This contributed to the annual value of $8.8 million for FY2024, which is 231.43% up from last year.
  • As of FY2024, Ligand Pharmaceuticals' Prepaid Assets stood at $8.8 million, which was up 231.43% from $2.7 million recorded in FY2023.
  • In the past 5 years, Ligand Pharmaceuticals' Prepaid Assets registered a high of $8.8 million during FY2024, and its lowest value of $2.3 million during FY2022.
  • Its 3-year average for Prepaid Assets is $4.6 million, with a median of $2.7 million in 2023.
  • In the last 5 years, Ligand Pharmaceuticals' Prepaid Assets slumped by 36.52% in 2022 and then surged by 231.43% in 2024.
  • Over the past 5 years, Ligand Pharmaceuticals' Prepaid Assets (Yearly) stood at $3.8 million in 2020, then declined by 6.57% to $3.6 million in 2021, then crashed by 36.52% to $2.3 million in 2022, then grew by 17.20% to $2.7 million in 2023, then skyrocketed by 231.43% to $8.8 million in 2024.